ID: ALA17762

Max Phase: Preclinical

Molecular Formula: C18H21N3O5

Molecular Weight: 359.38

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCCC(=O)OC1CCn2c1nc1c2C(=O)C(C)=C(NC(C)=O)C1=O

Standard InChI:  InChI=1S/C18H21N3O5/c1-4-5-6-12(23)26-11-7-8-21-15-14(20-18(11)21)17(25)13(19-10(3)22)9(2)16(15)24/h11H,4-8H2,1-3H3,(H,19,22)

Standard InChI Key:  HJXZLQMYRPWKPJ-UHFFFAOYSA-N

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 359.38Molecular Weight (Monoisotopic): 359.1481AlogP: 1.85#Rotatable Bonds: 5
Polar Surface Area: 107.36Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 0HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.70CX Basic pKa: 1.96CX LogP: 0.40CX LogD: 0.40
Aromatic Rings: 1Heavy Atoms: 26QED Weighted: 0.80Np Likeness Score: 0.32

References

1. Schulz WG, Islam I, Skibo EB..  (1995)  Pyrrolo[1,2-a]benzimidazole-based quinones and iminoquinones. The role of the 3-substituent on cytotoxicity.,  38  (1): [PMID:7837221] [10.1021/jm00001a016]

Source